| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/01/2008 | US20080102121 exhibit a bimodal or multimodal release profile; solid oral dosage forms |
| 05/01/2008 | US20080102120 particle distribution is more homogeneous than in the prior art; D50 of said valsartan particles is 150 mu m or below and that the valsartan particles have a maximum diameter of no more than 1100 mu m |
| 05/01/2008 | US20080102117 Base material for dry direct tableting comprising low-substituted hydroxypropyl cellulose |
| 05/01/2008 | US20080102116 contains a super disintegrant or an effervescent couple including a foaming agent; core is partially covered by preformed shell coverings shaped to expose at least a part of the core for activation upon exposure to bodily fluids |
| 05/01/2008 | US20080102115 Modified coagulation factor IX polypeptides and use thereof for treatment |
| 05/01/2008 | US20080102112 Chlamydia vaccines |
| 05/01/2008 | US20080102111 Anticancer Composition for Oral Use Comprising Liposome Containing Phytosterols and Prevention or Treatment for Cancer Using the Liposome |
| 05/01/2008 | US20080102109 Methods of enhancing solubility of agents |
| 05/01/2008 | US20080102107 Compositions and methods for transdermal joint pain therapy |
| 05/01/2008 | US20080102104 formed of copolyesters of polycaprolactone or a copolyester of epsilon -caprolactone and at least one cyclic monomer selected from the group consisting of lactide, glycolide and trimethylene carbonate |
| 05/01/2008 | US20080102102 Methods And Compositions For Decreasing Saliva Production |
| 05/01/2008 | US20080102100 treating the lens with a dispersing agent and a metal agent; may be worn continuously, for several days or more without removal for cleaning |
| 05/01/2008 | US20080102099 comprising: a viscoelastic solution comprising hyaluronic acid (HA); a drug selected from the group consisting of a steroid drug, quinolone, a non-steroid anti-inflammatory drug, an immunosuppressant and a drug that is compatible with the implant; and chitosan |
| 05/01/2008 | US20080102097 drug depot that encapsulates an anti-inflammatory agent, wherein the depot solidifies in situ when placed in a subject; the anti-inflammatory agent may be a NF- kappa B inhibitor, capable of blocking the production of pro-inflammatory cytokines at the macrophage nucleus |
| 05/01/2008 | US20080102089 topical application of a composition of urea and a chemotherapeutic agent such as sclerosing agents, vasodilators and botulinum toxin; spider veins, erectile dysfunction and facial wrinkles |
| 05/01/2008 | US20080102087 Compositions and methods for vaccinating against hsv-2 |
| 05/01/2008 | US20080102085 Vaccines for treatment of Aids; protein or polynucleotide is delivered via a bombardment approach |
| 05/01/2008 | US20080102084 Anti-cancer DNA Vaccine Employing Plasmids Encoding Mutant Oncoprotein Antigen and Calreticulin |
| 05/01/2008 | US20080102082 Policosanols and red yeast combined with astaxanthin and/or folic acid; antioxidant and antihypercholesterolemia activity |
| 05/01/2008 | US20080102078 Mutated e. coli heat-labile enterotoxin |
| 05/01/2008 | US20080102077 Nucleic and Protein Sequences from the Hxhv Virus and Uses Thereof |
| 05/01/2008 | US20080102070 SCDs As Modifiers of the p53 Pathway and Methods of Use |
| 05/01/2008 | US20080102068 Mitotic Kinesin Inhibitors |
| 05/01/2008 | US20080102066 Ultrapure transferrin for pharmaceutical compositions |
| 05/01/2008 | US20080102053 Containing alcohol, pH sensitive viscosity builders, plasticizer and water; fast drying, flaking resistant wound protective films; easy application and removal; remains in place without pooling; povidone-iodine based |
| 05/01/2008 | US20080102052 Aldehyde conjugated flavonoid preparations |
| 05/01/2008 | US20080102043 Antimicrobial flavor and oral care compositon containing the same |
| 05/01/2008 | US20080102042 Dentifrices containing N-acyl derivative of hydroxyproline; periodontal disease |
| 05/01/2008 | US20080102038 Clobetasol spray |
| 05/01/2008 | US20080102037 Stable pharmaceutical budesonide preparation for producing propellant-free aerosols |
| 05/01/2008 | US20080102034 Antihyperplastic agent preparation applicable to angiography catheter; enhancing artery and/or vein imaging; side effect reduction; rapid, efficient absorption through capillary walls |
| 05/01/2008 | US20080102033 Antihyperplastic agent preparation applicable to angiography catheter; enhancing artery and/or vein imaging; side effect reduction; rapid, efficient absorption through capillary walls |
| 05/01/2008 | US20080102032 Methods of Treating Diabetes Using Inhibitors of ARNT2 |
| 05/01/2008 | US20080102031 4-[(4-N,N-diethylaminocarbonyl)phenyl]-spiro[2H,1-benzopyran-2,4'-piperidine; ligands of delta opioid receptor; analgesic, anxiolitic, antidepressant, analgesic; gastrointestinal disorders, neurodegenerative diseases; side effect reduction |
| 04/30/2008 | EP1916297A2 Cell separation compositions and methods |
| 04/30/2008 | EP1916260A1 Heparin-like compounds, their preparation and use to prevent arterial thrombosis associated with vascular injury and interventions |
| 04/30/2008 | EP1916254A2 17alpha-alkyl-17beta-oxy-estratriene and intermediates for its production, use of 17alpha-alkyl-17beta-oxy-estratriene for manufacturing medicine and pharmaceutical preparations |
| 04/30/2008 | EP1916251A1 Erianin salts, their preparation methods and pharmaceutical compositions containing the same |
| 04/30/2008 | EP1916249A1 3-(benzo[d][1,3]dioxol-5-ylmethyl)-4-(thio)oxo-2-(thio)oxo-azolidin-5-ylidene derivatives as antibacterial agents |
| 04/30/2008 | EP1916248A1 Furanone derivatives as cysteine protease inhibitors |
| 04/30/2008 | EP1916247A1 Activator of peroxisome proliferator activated receptor |
| 04/30/2008 | EP1916245A1 Indole derivative having pgd2 receptor antagonist activity |
| 04/30/2008 | EP1916241A1 Crystal of phenylalanine derivative, process for producing the same and use thereof |
| 04/30/2008 | EP1916239A1 Pyridone compound |
| 04/30/2008 | EP1916234A1 Cyclopropanecarboxylic acid compound |
| 04/30/2008 | EP1916003A1 Thymidine analogs for imaging |
| 04/30/2008 | EP1916002A1 Method for prevention of degradation of thermally unstable substance |
| 04/30/2008 | EP1915996A1 Agents for treating intraocular inflammation caused by irradiation with lasers, containing 1,4-dihydropyridine derivatives |
| 04/30/2008 | EP1915995A1 Aqueous solution preparation containing camptothecins |
| 04/30/2008 | EP1915994A1 Cyclic amine derivative containing ppar regulator |
| 04/30/2008 | EP1915993A1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 04/30/2008 | EP1915992A1 Use of cyclooxygenase inhibitors and antimuscarinic agents for the treatment of incontinence |
| 04/30/2008 | EP1915991A1 Cartilage regeneration-promoting agent |
| 04/30/2008 | EP1915990A1 Sustained release preparation |
| 04/30/2008 | EP1915624A1 Amyloid beta receptor and uses thereof |
| 04/30/2008 | EP1915448A1 Nucleic acid agents for downregulating h19, and methods of using same |
| 04/30/2008 | EP1915387A1 Novel glucopyranose esters and glucofuranose esters of alkyl- fumarates and their pharmaceutical use |
| 04/30/2008 | EP1915382A2 Hepatitis c serine protease inhibitors and uses therefor |
| 04/30/2008 | EP1915381A1 Boron compounds useful in bnct |
| 04/30/2008 | EP1915380A1 Process for the preparation of n,n´- disubstituted oxabispidines |
| 04/30/2008 | EP1915379A1 Olanzapine analogs and methods of use thereof |
| 04/30/2008 | EP1915378A1 Viral polymerase inhibitors |
| 04/30/2008 | EP1915377A1 Pyrazolo pyrimidines useful as aurora kinase inhibitors |
| 04/30/2008 | EP1915375A1 Derivatives of 5-pyridinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics |
| 04/30/2008 | EP1915374A2 2-indolyl imidazo[4,5-d]phenanthroline derivatives and their use in the treatment of cancer |
| 04/30/2008 | EP1915373A1 Heterobicyclic compounds useful as p38 kinase inhibiting agents |
| 04/30/2008 | EP1915372A1 Indole derivatives as crth2 receptor antagonists |
| 04/30/2008 | EP1915371A2 Bridged n-bicyclic sulfonamido inhibitors of gamma secretase |
| 04/30/2008 | EP1915370A1 Pyrazole derivatives, their manufacture and their use as pharmaceutical agents |
| 04/30/2008 | EP1915369A1 Novel substituted 1,2,3-t ii azolylmethyl-benzothiophene or -indole and their use as leukotiiene biosynthesis inhibitors |
| 04/30/2008 | EP1915368A1 Salts and polymorphs of a vergf-r inhibitor |
| 04/30/2008 | EP1915367A1 Heteroarylcarbamoylbenzene derivatives for the treatment of diabetes |
| 04/30/2008 | EP1915366A2 Piperazine derivative renin inhibitors |
| 04/30/2008 | EP1915365A2 Carboxamide compound and use of the same |
| 04/30/2008 | EP1915364A1 Pyrazole derivatives as therapeutic agents |
| 04/30/2008 | EP1915363A1 Oxopyridyl quinoline amides as nk3 receptor modulators |
| 04/30/2008 | EP1915362A1 Amide alkyl pyridiyl quinolines as nk3 receptor modulators |
| 04/30/2008 | EP1915361A1 Alkylpyridyl quinolines as nk3 receptor modulators |
| 04/30/2008 | EP1915357A1 2-hydroxy-propionic acid derivatives and 3-hydroxy-benzofuran-2-one derivatives with affinity for the gaba-b-receptor |
| 04/30/2008 | EP1915356A1 Therapeutic agents |
| 04/30/2008 | EP1915355A1 Therapeutic agents |
| 04/30/2008 | EP1915354A1 Novel benzothiazolone derivatives |
| 04/30/2008 | EP1915352A1 Compounds for the treatment of alzheimer's disease |
| 04/30/2008 | EP1915351A1 Quinazoline derivatives useful in cancer treatment |
| 04/30/2008 | EP1915350A1 Amide derivatives |
| 04/30/2008 | EP1915349A2 Process for preparing pure amorphous rosuvastatin calcium |
| 04/30/2008 | EP1915347A1 New 1 , 2 -diaryl pyrazoles useful as analgetic and anti-inflammatory agents |
| 04/30/2008 | EP1915345A1 Fluoro substituted 2-oxo azepan derivatives |
| 04/30/2008 | EP1915342A1 A novel hydroxamic acid derivative as peptide deformylase inhibitor and manufacturing method thereof |
| 04/30/2008 | EP1915341A2 Compounds and compositions as tpo mimetics |
| 04/30/2008 | EP1915339A1 Beta-secretase inhibitors for use in the treatment of alzheimer's disease |
| 04/30/2008 | EP1915338A2 Androgen modulators |
| 04/30/2008 | EP1915334A2 Novel salts of fumaric acid monoalkylesters and their pharmaceutical use |
| 04/30/2008 | EP1915330A1 Fluorination process of anilide derivatives and benzothiazole fluorinate derivatives as in vivo imaging agents |
| 04/30/2008 | EP1915198A1 Hair and/or scalp care compositions incorporating visnadin |
| 04/30/2008 | EP1915166A2 Marrubiin and composition for reducing snoring, package and method |
| 04/30/2008 | EP1915164A1 The use of charcoal for treating inflammatory conditions |
| 04/30/2008 | EP1915163A2 Compositions of polyacids and polyethers and methods for their use as dermal fillers |
| 04/30/2008 | EP1915162A1 Modulators |
| 04/30/2008 | EP1915161A2 Antisense antibacterial method and compound |